Swiss-based CDMO Lonza said it has been given the green light by regulators for its $5.5 billion deal to buy U.S.-based contract capsule and drug producer…
Takeda Pharma is positioning itself to take over stem cell production in Europe from its partner TiGenix by 2021 after Swissmedic accepted for review the file…
Just a month after FDA staff gave a ringing endorsement to Pfizer's biosimilar for Amgen's blockbuster Epogen, the agency rejected the drug.
Russia is pushing back on an issue that has raised concerns around the world: cancer drug prices.
Lucid Pharma issued a nationwide voluntary recall of about 69,000 extended-release capsules of venlafaxine hydrochloride, which is used as an antidepressant.
The FDA released a warning letter sent to Chinese API maker Qinhuangdao Zizhu Pharmaceutical in April that outlined data integrity problems.
Seqirus said it has achieved an industry first by producing a cell-based influenza vaccine on a commercial scale using a virus grown in cells.
Citing sterility concerns, Hospira, a subsidiary of pharma giant Pfizer, is voluntarily recalling vials used to inject sodium bicarbonate during surgery and in…
Japanese pharmaceutical giant Takeda said it has completed construction of its new $111 million manufacturing plant in Oranienburg, Germany.
The FDA has banned drugs manufactured at three facilities in India operated by Ipca Laboratories as a result of ongoing concerns.